The Inova Neurosciences Research Program recognizes that basic, translational, and clinical research are not separate entities but are parts of an integrated approach to advance the treatment and cure of different neurological diseases. We are playing a key role in the advancement of cutting edge neurological therapies and technologies as active collaborators in multidisciplinary studies and clinical trials with academic and private industry partners.
Our clinicians are committed to advancing the science within their specialties and helping patients to have pathways to clinical and the ability to participate in clinical trials research. We welcome engagement and collaboration with research investigators and institutions and of course our patients to speak to their provider about a clinical study of interest.
The Integrated Health Research Institute of Virginia (iTHRIV) is an interdisciplinary collaboration of public and private institutions across the Commonwealth of Virginia with shared research resources and clinical best practices that creates team science and community engagement to produce advances in patient care. Among the research collaborations we have with University of Virginia is the iTHRIV Pilot Translational and Clinical Studies Program which is a core component of the National Institutes of Health-funded Clinical and Translational Sciences Award (CTSA), "The integrated Translational Health Research Institute of Virginia (iTHRIV): Using Data to Improve Health." The goal of the iTHRIV Program is to help research teams transition from early-stage seed grants and proof-of-concept studies to externally-funded translational research and clinical application. The iTHRIV partner institutions are Inova, the University of Virginia, Virginia Tech and the Carilion Clinic.
Through a multi-year memo of understanding between Inova and George Mason University, we created a translational research laboratory under the guidance of our Director of Translational Research, Dr. Robert Lipsky. The laboratory performs genetic and protein biomarker studies that are integrated into clinical patient information to develop innovative methods for personalized healthcare. Inova Neurosciences has a bioinformatics team working with scientists at the George Mason University, College of Medicine, School of Systems Biology to analyze data generated from Inova genomic and clinical research efforts. This approach will impact our patients and transform healthcare from reactive to predictive practices. The goal is to increase successful patient outcomes while reducing adverse reactions to treatment.
To date, our efforts at the Inova Neurosciences Research Program involve clinical trials and outcomes studies overseen by our neuroscience physicians and researchers. To learn more:
